Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2015 3
2016 4
2017 5
2018 9
2019 11
2020 13
2021 7
2022 5
2023 8
2024 1
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ; Amyloid PET Study Group; Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, Miller BL, Rosen HJ, Landau SM, Villemagne VL, Rowe CC, Lee DY, Na DL, Seo SW, Sarazin M, Roe CM, Sabri O, Barthel H, Koglin N, Hodges J, Leyton CE, Vandenberghe R, van Laere K, Drzezga A, Forster S, Grimmer T, Sánchez-Juan P, Carril JM, Mok V, Camus V, Klunk WE, Cohen AD, Meyer PT, Hellwig S, Newberg A, Frederiksen KS, Fleisher AS, Mintun MA, Wolk DA, Nordberg A, Rinne JO, Chételat G, Lleo A, Blesa R, Fortea J, Madsen K, Rodrigue KM, Brooks DJ. Ossenkoppele R, et al. Among authors: verfaillie sc. JAMA. 2015 May 19;313(19):1939-49. doi: 10.1001/jama.2015.4669. JAMA. 2015. PMID: 25988463 Free PMC article.
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease Continuum.
Coomans EM, Verberk IMW, Ossenkoppele R, Verfaillie SCJ, Visser D, Gouda M, Tuncel H, Wolters EE, Timmers T, Windhorst AD, Golla SSV, Scheltens P, van WM, Flier D, van Berckel BNM, Teunissen CE. Coomans EM, et al. Among authors: verfaillie scj. J Nucl Med. 2023 Mar;64(3):437-443. doi: 10.2967/jnumed.122.264279. Epub 2022 Oct 13. J Nucl Med. 2023. PMID: 36229187 Free PMC article.
Grey zone amyloid burden affects memory function: the SCIENCe project.
Ebenau JL, Verfaillie SCJ, van den Bosch KA, Timmers T, Wesselman LMP, van Leeuwenstijn M, Tuncel H, Golla SVS, Yaqub MM, Windhorst AD, Prins ND, Barkhof F, Scheltens P, van der Flier WM, van Berckel BNM. Ebenau JL, et al. Among authors: verfaillie scj. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):747-756. doi: 10.1007/s00259-020-05012-5. Epub 2020 Sep 4. Eur J Nucl Med Mol Imaging. 2021. PMID: 32888039 Free PMC article.
Longitudinal associations between amyloid and symptoms of depression and anxiety in subjective cognitive decline: the impact of personality characteristics.
Trieu C, van Leeuwenstijn MSSA, Schlüter LM, Ebenau JL, Verberk IMW, Sikkes SAM, Verfaillie SCJ, van de Giessen E, Teunissen CE, van der Flier WM, van Harten AC. Trieu C, et al. Among authors: verfaillie scj. Front Psychiatry. 2025 Jun 10;16:1572174. doi: 10.3389/fpsyt.2025.1572174. eCollection 2025. Front Psychiatry. 2025. PMID: 40557139 Free PMC article.
Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals.
Ebenau JL, Visser D, Verfaillie SCJ, Timmers T, van Leeuwenstijn MSSA, Kate MT, Windhorst AD, Barkhof F, Scheltens P, Prins ND, Boellaard R, van der Flier WM, van Berckel BNM. Ebenau JL, et al. Among authors: verfaillie scj. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):410-422. doi: 10.1007/s00259-022-05958-8. Epub 2022 Sep 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 36071221 Free PMC article.
Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results.
Slot RER, Verfaillie SCJ, Overbeek JM, Timmers T, Wesselman LMP, Teunissen CE, Dols A, Bouwman FH, Prins ND, Barkhof F, Lammertsma AA, Van Berckel BNM, Scheltens P, Sikkes SAM, Van der Flier WM. Slot RER, et al. Among authors: verfaillie scj. Alzheimers Res Ther. 2018 Aug 7;10(1):76. doi: 10.1186/s13195-018-0390-y. Alzheimers Res Ther. 2018. PMID: 30081935 Free PMC article.
Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID-19: A TSPO PET Study.
Visser D, Golla SSV, Palard-Novello X, Verfaillie SCJ, Verveen A, Koch DW, Rikken RM, van de Giessen E, Nieuwkerk PT, den Hollander ME, Horn J, van Heugten CM, de Jong MD, van den Wijngaard CC, van der Maaden T, van Os YMG, Prins M, Visser-Meily JMA, Schober P, Schuit RC, Kassiou M, Windhorst AD, Biere-Rafi S, Appelman B, van Vugt M, Barkhof F, van Berckel BNM, Boellaard R, Knoop H, Tolboom N. Visser D, et al. Among authors: verfaillie scj. J Nucl Med. 2025 Nov 3;66(11):1787-1794. doi: 10.2967/jnumed.124.269297. J Nucl Med. 2025. PMID: 40935606 Free PMC article.
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.
Verberk IMW, Slot RE, Verfaillie SCJ, Heijst H, Prins ND, van Berckel BNM, Scheltens P, Teunissen CE, van der Flier WM. Verberk IMW, et al. Among authors: verfaillie scj. Ann Neurol. 2018 Nov;84(5):648-658. doi: 10.1002/ana.25334. Epub 2018 Oct 4. Ann Neurol. 2018. PMID: 30196548 Free PMC article.
Neurobiological basis and risk factors of persistent fatigue and concentration problems after COVID-19: study protocol for a prospective case-control study (VeCosCO).
Verveen A, Verfaillie SCJ, Visser D, Csorba I, Coomans EM, Koch DW, Appelman B, Barkhof F, Boellaard R, de Bree G, van de Giessen EM, Golla S, van Heugten CM, Horn J, Hulst HE, de Jong MD, Kuut TA, van der Maaden T, van Os YMG, Prins M, Slooter AJC, Visser-Meily JMA, van Vugt M, van den Wijngaard CC, Nieuwkerk PT, Knoop H, Tolboom N, van Berckel BNM. Verveen A, et al. Among authors: verfaillie scj. BMJ Open. 2023 Jun 30;13(6):e072611. doi: 10.1136/bmjopen-2023-072611. BMJ Open. 2023. PMID: 37399444 Free PMC article.
58 results